Elekta gets ok from China

The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
Elekta Compact is a competitive linear accelerator for high quality conventional radiotherapy, configured for countries in need of rapid build-up of additional treatment capacity. Elekta Compact is based on a combination of technology from Elekta and from the product platform developed by the Chinese company BMEI, which Elekta acquired in 2006.

In May 2008 Elekta received SFDA approval to export Elekta Compact outside China and in June 2008 Elekta completed the process of adding CE marking, allowing Elekta Compact to be marketed in Europe, Latin America and Asia.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders.

Kommentera en artikel
Utvalda artiklar


Sänd till en kollega